Jaydutt V Vadgama

Dr. Jaydutt V Vadgama is a Professor in the Department of Internal Medicine at Charles R. Drew University of Medicine and Science, where he directs significant cancer research initiatives focused on health disparities. His work bridges basic science and clinical applications, with particular emphasis on understanding cancer mechanisms in underserved populations.

Dr. Vadgama's research interests span multiple critical areas in oncology, including breast cancer biology, molecular pathways of cancer progression, and the intersection of metabolic disorders like diabetes with cancer development. His work particularly focuses on health disparities affecting African American and Hispanic women, investigating how factors like obesity, diabetes, and hypertension exacerbate cancer risk in these populations. His laboratory explores molecular mechanisms including epithelial-mesenchymal transition, STAT3 signaling, and inflammatory pathways in cancer progression.

Analysis of his recent publications reveals a strong trend toward translational research, with numerous studies examining therapeutic interventions, drug development, and biomarker discovery. His work consistently addresses the molecular basis of cancer disparities, with significant contributions to understanding breast cancer in minority populations. Recent publications show increasing focus on nanotechnology for drug delivery, natural compounds for cancer prevention, and the molecular underpinnings of treatment resistance.

Dr. Vadgama has secured substantial research funding as Principal Investigator on multiple NIH grants, including the CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities (U54CA143931) and the Center for Accelerating Excellence in Translational Science (AXIS) (U54MD007598). His research program has been continuously funded by the NIH since 1987, demonstrating sustained scientific impact.

His laboratory work spans molecular oncology, cancer cell biology, and translational research, with particular expertise in studying breast cancer in minority populations. The research program integrates basic science approaches with clinical applications to address cancer health disparities through multiple NIH-funded initiatives.